FDA Label for Rexall Feminine Maximum Strength Anti-itch

View Indications, Usage & Precautions

Rexall Feminine Maximum Strength Anti-itch Product Label

The following document was submitted to the FDA by the labeler of this product Dolgencorp, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredients



Benzocaine 20%

Resorcinol 3%


Purpose



External Analgesic

External Analgesic


Use



  • Temporarily relieves itching

Warnings



For external use only


Otc - When Using



When using this product avoid contact with eyes


Otc - Stop Use



Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Also, do not use if you have an unusual or abnormal vaginal discharge except under the supervision of a physician.

Do not apply over large areas of the body.


Otc - Keep Out Of Reach Of Children



Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.


Directions



adults and children 12 years and older

apply a fingertip amount (approximately 1-inch strip) to Tthe affected area not more than 3 to 4 times daily

children under 12 years

consult a doctor


Other Information



store at 20°-25°C (68°-77°F)


Inactive Ingredients



aloe vera gel, carbomer, cetyl alcohol, corn oil, disodium EDTA, fragrance, glyceryl stearate, isopropyl myristate, isopropyl palmitate, lanolin, methyl-4 hydroxybenzoate, mineral oil, PEG-100 stearate, propylene glycol, purified water, stearic acid, stearyl alcohol, triethanolamine, vitamin A, E & D


Principal Display Panel - 28 G Carton Label



REXALL FEMININE MAXIMUM STRENGTH ANTI-ITCH CREAM

NET WT 1 OZ (28 g)


* Please review the disclaimer below.